DNA synthesis in normal and leucemic cells as related to therapy with cytotoxic drugs.
D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001853:Bone Marrow / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D001854:Bone Marrow Cells; D003561:Cytarabine / Q000494:pharmacology / Q000627:therapeutic use; D004247:DNA / Q000096:biosynthesis*; D004254:DNA Nucleotidyltransferases / Q000378:metabolism; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003630:Daunorubicin / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D007945:Leukemia, Lymphoid / Q000097:blood* / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000097:blood* / Q000188:drug therapy; D007962:Leukocytes / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D008727:Methotrexate / Q000627:therapeutic use; D011239:Prednisolone / Q000494:pharmacology / Q000627:therapeutic use; D013762:Tetrahydrofolate Dehydrogenase / Q000097:blood; D013937:Thymidine Kinase / Q000378:metabolism; D013942:Thymine Nucleotides / Q000378:metabolism
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D013942:Thymine Nucleotides; D003561:Cytarabine; D004317:Doxorubicin; D004247:DNA; D011239:Prednisolone; D013762:Tetrahydrofolate Dehydrogenase; D013937:Thymidine Kinase; D004254:DNA Nucleotidyltransferases; D008727:Methotrexate; D003630:Daunorubicin